A study revealed that METTL3-mediated m6A modification improves the stability of transcription factor activated enhancer binding protein 2C mRNA, thus increasing the abundance of DNA repair genes, which endows spermatogonioma cells with resistance to DNA damage induced by cisplatin treatment, promoting tumor cell survival (131). Here, METTL3 is linked to neoplasm.